Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Viruses vol. 17, no. 12 (2025), p. 1613-1633
1. Verfasser:	Lalu, Anjana C
Weitere Verfasser:	Kundil, Varun Thachan, Joseph Bristow Ben, Dev Radul R., Amritha, Thaikkad, Subair Suhail, Raju Rajesh, Abhithaj, Jayanandan
Veröffentlicht:	MDPI AG
Schlagworte:	Food & Drug Administration > FDA Australia Physiology RNA polymerase RNA-directed RNA polymerase Toxicity Binding sites Hydrogen Drug development Computer applications DNA-directed RNA polymerase Antiviral agents Bioavailability Proteins Crystal structure Simulation Fatalities RNA viruses Pharmacokinetics FDA approval Pamidronic acid Conserved sequence Bisphosphonates Ligands Viruses Homology
Online-Zugang:	Citation/Abstract Full Text + Graphics Full Text - PDF
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!

Schreiben Sie den ersten Kommentar!